PubMed

Pharmacotherapy for heart failure in patients with renal insufficiency.

Shlipak MG.

Ann Intern Med. 2003 Jun 3;138(11):917-24. Review.PMID: 12779302 [PubMed - indexed for MEDLINE]Related articlesFree article

Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?

Ahmed A.

J Am Geriatr Soc. 2002 Jul;50(7):1297-300.PMID: 12133029 [PubMed - indexed for MEDLINE]Related articles

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.

[No authors listed]

Prescrire Int. 2005 Oct;14(79):180-6.PMID: 16285075 [PubMed - indexed for MEDLINE]Related articles

Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.

Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS.

Am J Med. 2007 Dec;120(12):1090.e1-8. Review.PMID: 18060931 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.

Berger AK, Duval S, Manske C, Vazquez G, Barber C, Miller L, Luepker RV.

Am Heart J. 2007 Jun;153(6):1064-73.PMID: 17540211 [PubMed - indexed for MEDLINE]Related articles

[Renal failure is an independent predictor of mortality in hospitalized heart failure patients and is associated with a worse cardiovascular risk profile]

Grigorian Shamagian L, Varela Román A, Pedreira Pérez M, Gómez Otero I, Virgós Lamela A, González-Juanatey JR.

Rev Esp Cardiol. 2006 Feb;59(2):99-108. Spanish. PMID: 16540030 [PubMed - indexed for MEDLINE]Related articlesFree article

Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study.

Majumdar SR, McAlister FA, Cree M, Chang WC, Packer M, Armstrong PW; ATLAS Study Group.

Clin Ther. 2004 May;26(5):694-703.PMID: 15220013 [PubMed - indexed for MEDLINE]Related articles

Update on therapy for heart failure.

DiBianco R.

Am J Med. 2003 Oct 15;115(6):480-8. Review.PMID: 14563505 [PubMed - indexed for MEDLINE]Related articles

Angiotensin-converting enzyme inhibitor use in older patients with heart failure and renal dysfunction.

Philbin EF, Santella RN, Rocco TA Jr.

J Am Geriatr Soc. 1999 Mar;47(3):302-8.PMID: 10078892 [PubMed - indexed for MEDLINE]Related articles

Risk-treatment mismatch in the pharmacotherapy of heart failure.

Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, Chong A, Stukel TA, Levy D, Laupacis A.

JAMA. 2005 Sep 14;294(10):1240-7.PMID: 16160132 [PubMed - indexed for MEDLINE]Related articlesFree article

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease.

Ezekowitz J, McAlister FA, Humphries KH, Norris CM, Tonelli M, Ghali WA, Knudtson ML; APPROACH Investigators.

J Am Coll Cardiol. 2004 Oct 19;44(8):1587-92.PMID: 15489090 [PubMed - indexed for MEDLINE]Related articles

Renal dysfunction in heart failure patients: what is the evidence?

Saltzman HE, Sharma K, Mather PJ, Rubin S, Adams S, Whellan DJ.

Heart Fail Rev. 2007 Mar;12(1):37-47. Epub 2007 Mar 29. Review.PMID: 17393304 [PubMed - indexed for MEDLINE]Related articles

How prevalent is hyperkalemia and renal dysfunction during treatment with spironolactone in patients with congestive heart failure?

Svensson M, Gustafsson F, Galatius S, Hildebrandt PR, Atar D.

J Card Fail. 2004 Aug;10(4):297-303.PMID: 15309695 [PubMed - indexed for MEDLINE]Related articles

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.

Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, Redelmeier DA.

N Engl J Med. 2004 Aug 5;351(6):543-51.PMID: 15295047 [PubMed - indexed for MEDLINE]Related articlesFree article

Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.

Tamirisa KP, Aaronson KD, Koelling TM.

Am Heart J. 2004 Dec;148(6):971-8.PMID: 15632880 [PubMed - indexed for MEDLINE]Related articles

Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort study.

McAlister FA, Ezekowitz J, Tonelli M, Armstrong PW.

Circulation. 2004 Mar 2;109(8):1004-9. Epub 2004 Feb 9.PMID: 14769700 [PubMed - indexed for MEDLINE]Related articlesFree article

Congestive heart failure: what should be the initial therapy and why?

Chatterjee K.

Am J Cardiovasc Drugs. 2002;2(1):1-6. Review.PMID: 14727993 [PubMed - indexed for MEDLINE]Related articles

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.

Anavekar NS, McMurray JJ, Velazquez EJ, Solomon SD, Kober L, Rouleau JL, White HD, Nordlander R, Maggioni A, Dickstein K, Zelenkofske S, Leimberger JD, Califf RM, Pfeffer MA.

N Engl J Med. 2004 Sep 23;351(13):1285-95.PMID: 15385655 [PubMed - indexed for MEDLINE]Related articlesFree article

[Pharmacotherapy of chronic heart failure]

Hoppe UC.

Z Arztl Fortbild Qualitatssich. 2003 Apr;97(2):113-9. German. PMID: 12806816 [PubMed - indexed for MEDLINE]Related articles

The renin-angiotensin system: the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure.

Hebert PR, Foody JM, Hennekens CH.

Curr Vasc Pharmacol. 2003 Mar;1(1):33-9. Review.PMID: 15320851 [PubMed - indexed for MEDLINE]Related articles